Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Jeffrey T L Smith. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Jeffrey T L Smith zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| EVP & Chief Medical Officer | 26 708 | |
| US:ALDR / Alder BioPharmaceuticals, Inc. | Managing Director | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Jeffrey T L Smith. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Jeffrey T L Smith ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-12 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | -9 310 | 26 708 | -25,85 | 22,67 | -211 090 | 605 564 | |
| 2026-01-12 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 17 666 | 36 018 | 96,26 | ||||
| 2026-01-05 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | -10 538 | 18 352 | -36,48 | 25,10 | -264 471 | 460 578 | |
| 2026-01-05 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 20 000 | 28 890 | 224,97 | ||||
| 2025-01-06 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
S - Sale | -11 110 | 8 890 | -55,55 | 14,92 | -165 807 | 132 675 | |
| 2025-01-06 |
|
4 | ZYME |
Zymeworks Inc.
Common Stock |
M - Exercise | 20 000 | 20 000 | |||||
| 2024-01-05 | 3 | ZYME |
Zymeworks Inc.
No securities are beneficially owned |
0 | ||||||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -100 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -100 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -60 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -50 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -50 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -85 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -35 000 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -13 636 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -13 636 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -31 818 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | -17 271 | 0 | -100,00 | ||||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | -21 502 | 0 | -100,00 | 18,00 | -387 036 | ||
| 2019-10-24 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
A - Award | 16 230 | 21 502 | 307,85 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -10 001 | 17 271 | -36,67 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -22 727 | 0 | -100,00 | ||||
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -32 728 | 5 272 | -86,13 | 18,44 | -603 504 | 97 216 |
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 001 | 38 000 | 35,72 | 3,46 | 34 653 | 131 670 |
| 2019-09-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 22 727 | 27 999 | 431,09 | 4,46 | 101 249 | 124 736 |
| 2019-04-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | X | -4 847 | 5 272 | -47,90 | 13,73 | -66 526 | 72 359 |
| 2019-04-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
A - Award | 9 288 | 10 119 | 1 117,69 | ||||
| 2019-02-08 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 044 | 0 | -100,00 | ||||
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 044 | 831 | -85,86 | 13,84 | -69 826 | 11 504 |
| 2018-12-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 044 | 5 875 | 606,98 | 0,99 | 4 994 | 5 816 |
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 5 044 | -49,98 | ||||
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 040 | 831 | -85,85 | 13,42 | -67 637 | 11 152 |
| 2018-11-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 10 084 | -33,32 | ||||
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 000 | 831 | -70,65 | 15,97 | -31 944 | 13 273 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 040 | 2 831 | -51,78 | 15,26 | -46 385 | 43 196 |
| 2018-10-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 15 124 | -25,00 | ||||
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -5 040 | 831 | -85,85 | 18,00 | -90 699 | 14 955 |
| 2018-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 20 164 | -20,00 | ||||
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -980 | 831 | -54,11 | 19,76 | -19 369 | 16 424 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 060 | 1 811 | -69,15 | 19,49 | -79 120 | 35 292 |
| 2018-08-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 25 204 | -16,66 | ||||
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 121 | 0 | -100,00 | ||||
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 161 | 831 | -93,60 | 15,49 | -188 364 | 12 872 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 12 992 | 63,38 | 0,99 | 4 990 | 12 862 |
| 2018-07-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 7 952 | 856,92 | 1,65 | 11 750 | 13 121 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 30 244 | -14,28 | ||||
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 121 | 7 121 | -50,00 | ||||
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 100 | 831 | -56,97 | 18,29 | -20 115 | 15 196 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -11 061 | 1 931 | -85,14 | 17,81 | -197 012 | 34 394 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 12 992 | 63,38 | 0,99 | 4 990 | 12 862 |
| 2018-06-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 7 952 | 856,92 | 1,65 | 11 750 | 13 121 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 121 | 14 242 | -33,33 | ||||
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -5 040 | 35 284 | -12,50 | ||||
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -12 161 | 831 | -93,60 | 15,03 | -182 758 | 12 488 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 121 | 12 992 | 121,29 | 1,65 | 11 750 | 21 437 |
| 2018-05-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 040 | 5 871 | 606,50 | 0,99 | 4 990 | 5 812 |
| 2018-02-21 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 60 000 | 60 000 | |||||
| 2017-12-18 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
The shares subject to this option shall vest and become exer |
A - Award | 50 000 | 50 000 | |||||
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -585 | 40 324 | -1,43 | ||||
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -585 | 831 | -41,31 | 20,00 | -11 700 | 16 620 |
| 2017-06-22 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 585 | 1 416 | 70,40 | 0,99 | 579 | 1 402 |
| 2017-01-31 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 85 000 | 85 000 | |||||
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 21 363 | -12,31 | ||||
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -500 | 831 | -37,57 | 23,62 | -11 810 | 19 628 |
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 500 | 1 331 | -65,26 | 22,61 | -56 518 | 30 090 |
| 2016-12-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 831 | 361,01 | 1,65 | 4 950 | 6 321 |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 24 363 | -10,96 | ||||
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -400 | 0 | -100,00 | 24,88 | -9 950 | |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 600 | 400 | -86,67 | 24,26 | -63 082 | 9 705 |
| 2016-11-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 27 363 | -9,88 | ||||
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -702 | 0 | -100,00 | 31,62 | -22 199 | |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 298 | 702 | -76,60 | 30,99 | -71 216 | 21 755 |
| 2016-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 30 363 | -8,99 | ||||
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 0 | -100,00 | 33,10 | -3 310 | |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 900 | 100 | -96,67 | 32,47 | -94 173 | 3 247 |
| 2016-09-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 33 363 | -8,25 | ||||
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -3 000 | 0 | -100,00 | 31,17 | -93 512 | ||
| 2016-08-17 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 1,65 | 4 950 | 4 950 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -16 090 | 0 | -100,00 | ||||
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -1 000 | 0 | -100,00 | 31,83 | -31 827 | ||
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -3 805 | 1 000 | -79,19 | 31,00 | -117 940 | 30 996 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -11 285 | 4 805 | -70,14 | 29,79 | -336 167 | 143 135 | |
| 2016-06-07 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 090 | 16 090 | 1,26 | 20 354 | 20 354 | ||
| 2016-02-02 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 100 000 | 100 000 | |||||
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -4 272 | 0 | -100,00 | ||||
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -4 272 | 0 | -100,00 | 37,24 | -159 104 | |
| 2015-12-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 272 | 4 272 | 0,38 | 1 645 | 1 645 | |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 4 272 | -47,72 | ||||
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 400 | 0 | -100,00 | 34,57 | -48 393 | |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 000 | 1 400 | -41,67 | 33,85 | -33 852 | 47 393 |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 500 | 2 400 | -38,46 | 32,70 | -49 054 | 78 486 |
| 2015-11-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 8 172 | -32,31 | ||||
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -100 | 0 | -100,00 | 32,83 | -3 283 | |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 800 | 100 | -97,44 | 32,24 | -122 495 | 3 224 |
| 2015-10-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 12 072 | -24,42 | ||||
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 500 | 0 | -100,00 | 38,83 | -58 241 | |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 400 | 1 500 | -61,54 | 38,30 | -91 924 | 57 453 |
| 2015-09-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 15 972 | -19,63 | ||||
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 45,64 | -178 003 | |
| 2015-08-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 19 872 | -16,41 | ||||
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 51,18 | -199 616 | |
| 2015-07-06 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 23 772 | -14,09 | ||||
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 41,53 | -161 969 | |
| 2015-06-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -7 202 | 0 | -100,00 | ||||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -7 202 | 0 | -100,00 | 38,47 | -277 027 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 202 | 7 202 | 0,06 | 396 | 396 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -54 616 | 7 202 | -88,35 | ||||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -54 616 | 0 | -100,00 | 38,92 | -2 125 496 | ||
| 2015-05-26 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | 54 616 | 54 616 | 0,06 | 3 004 | 3 004 | ||
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 27 672 | -12,35 | ||||
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 25,67 | -100 130 | |
| 2015-05-05 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 31 572 | -10,99 | ||||
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 27,43 | -106 995 | |
| 2015-04-03 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -3 900 | 35 472 | -9,91 | ||||
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -3 900 | 0 | -100,00 | 26,25 | -102 357 | |
| 2015-03-04 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 900 | 3 900 | 0,38 | 1 502 | 1 502 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -1 200 | 39 372 | -2,96 | ||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -1 200 | 0 | -100,00 | 28,27 | -33 921 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 200 | 1 200 | 0,38 | 462 | 462 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -2 700 | 40 572 | -6,24 | ||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 50 000 | 50 000 | |||||
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | X | -2 700 | 0 | -100,00 | 27,89 | -75 316 | |
| 2015-01-28 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 700 | 2 700 | 0,38 | 1 040 | 1 040 | |
| 2014-11-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -9 090 | 0 | -100,00 | 16,91 | -153 735 | ||
| 2014-11-25 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
S - Sale | -20 000 | 9 090 | -68,75 | 15,71 | -314 118 | 142 767 | |
| 2014-07-10 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 35 000 | 35 000 | |||||
| 2014-05-09 |
|
4 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 13 636 | 13 636 | |||||
| 2014-05-07 | 3 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
58 180 | ||||||||
| 2014-05-07 | 3 | ALDR |
ALDER BIOPHARMACEUTICALS INC
Common Stock |
58 180 |